Alere, a global leader in rapid diagnostics, today announced that its Alere HIV Combo, a rapid point-of-care fourth-generation test that detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, has been awarded World Health Organization (WHO) prequalification, making it available for public sector procurement in resource-limited countries.
17 July 2016 | Alere press release
POC is likely to grow in emerging markets, where limited resources and local conditions make traditional lab-based testing less practical.
13 July 2016 | Genetic Engineering & Biotechnology News
The INSTI HIV Self Test will be commercially available in the UK, France and other key European countries by the fourth quarter of this year. The product will be marketed through retail locations and certain e-commerce platforms.
12 July 2016 | bioLytical press release
China is now aiming to make HIV self-test kits widely available to the internet-savvy generation. Its Centre for Aids/STD Control and Prevention (NCAids) said it would make the kits widely accessible through online outlets and pharmacies, which could “reach out to those under the radar, helping to link them to care”.
27 June 2016 | South China Morning Post
The UK’s leading HIV and sexual health charity has linked up with BioSure to launch a ‘groundbreaking’ pilot today, releasing 4,500 free HIV tests which are available to people at high risk of HIV, including men who have sex with men, and black Africans. Like a home pregnancy test, you do the test yourself and see the result within a few minutes.
27 June 2016 | Terrence Higgins Trust
A quick swab of the gums and people know their test results. In Malawi, many people didn't get tested for HIV before because that meant visiting a clinic - but they didn't want health officials to know their status.
30 March 2016 | AllAfrica
Rheonix Inc. a developer of fully automated molecular testing solutions, has completed development and testing of a microfluidic system and assay to simultaneously detect host anti-HIV antibodies and viral RNA in a single specimen of saliva or blood. The Rheonix system will improve HIV testing by detecting
early, acute HIV infection and addressing the well - known “seroconversion window” when antibodies are not yet detectable, thus eliminating the need for multiple patient visits to health care providers.
16 March 2016 | Rheonix press release
In a study appearing in the Feb. 16 issue of JAMA, Philip J. Peters, M.D., of the Centers for Disease Control and Prevention, Atlanta, and colleagues evaluated the performance of an HIV antigen/antibody (Ag/Ab) combination assay to detect acute HIV infection (early infection) compared with pooled HIV RNA testing, the reference standard.
22 February 2016 | Eurekalert Medicine & Health
After years of debate about the merits of home HIV testing, a ban has been lifted on pharmacist sales of do-it-yourself HIV tests.
09 February 2016 | Health-E News
The US based Global Health Investment Fund (GHIF), which was set up by the Bill and Melinda Gates Foundation and investment bank JPMorgan in 2013, will hand Sydney based Atomo Diagnostics fresh funds as it seeks to scale up production of its self testing devices, expand its sales activities and the commercial rollout of its products in developing countries.
14 January 2016 | Sydney Morning Herald